These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
259 related articles for article (PubMed ID: 16275888)
101. Synergistic effect of cefepime on the phagocytic killing of Staphylococcus aureus by human polymorphonuclear leucocytes and the determination of this effect by means of nitrite production. Sultan N; Cirak MY; Erbaş D Microbios; 2000; 103(405):97-106. PubMed ID: 11092191 [TBL] [Abstract][Full Text] [Related]
103. Anti-CD45 isoform antibodies enhance phagocytosis and gene expression of IL-8 and TNF-alpha in human neutrophils by differential suppression on protein tyrosine phosphorylation and p56lck tyrosine kinase. Yu C; Yu HS; Sun KH; Hsieh SC; Tsai CY Clin Exp Immunol; 2002 Jul; 129(1):78-85. PubMed ID: 12100025 [TBL] [Abstract][Full Text] [Related]
104. LIGHT, a new member of the TNF superfamily. Yang D; Zhai Y; Zhang M J Biol Regul Homeost Agents; 2002; 16(3):206-10. PubMed ID: 12456019 [No Abstract] [Full Text] [Related]
105. Phagocytosis and killing of Staphylococcus aureus by bovine neutrophils after priming by tumor necrosis factor-alpha and the des-arginine derivative of C5a. Rainard P; Riollet C; Poutrel B; Paape MJ Am J Vet Res; 2000 Aug; 61(8):951-9. PubMed ID: 10951989 [TBL] [Abstract][Full Text] [Related]
106. Network communications: lymphotoxins, LIGHT, and TNF. Ware CF Annu Rev Immunol; 2005; 23():787-819. PubMed ID: 15771586 [TBL] [Abstract][Full Text] [Related]
107. Constitutive expression of LIGHT on T cells leads to lymphocyte activation, inflammation, and tissue destruction. Shaikh RB; Santee S; Granger SW; Butrovich K; Cheung T; Kronenberg M; Cheroutre H; Ware CF J Immunol; 2001 Dec; 167(11):6330-7. PubMed ID: 11714797 [TBL] [Abstract][Full Text] [Related]
108. Creation of a LIGHT mutant with the capacity to evade the decoy receptor for cancer therapy. Morishige T; Yoshioka Y; Inakura H; Tanabe A; Yao X; Tsunoda S; Tsutsumi Y; Mukai Y; Okada N; Nakagawa S Biomaterials; 2010 Apr; 31(12):3357-63. PubMed ID: 20117833 [TBL] [Abstract][Full Text] [Related]
109. Modulatory activity of chemotherapeutic agents on phagocytosis and intracellular bactericidal activity of human polymorphonuclear and mononuclear phagocytes. Pruzanski W; Saito S; DeBoer G Cancer Res; 1983 Mar; 43(3):1420-5. PubMed ID: 6337708 [TBL] [Abstract][Full Text] [Related]
110. Herpesvirus entry mediator ligand (HVEM-L), a novel ligand for HVEM/TR2, stimulates proliferation of T cells and inhibits HT29 cell growth. Harrop JA; McDonnell PC; Brigham-Burke M; Lyn SD; Minton J; Tan KB; Dede K; Spampanato J; Silverman C; Hensley P; DiPrinzio R; Emery JG; Deen K; Eichman C; Chabot-Fletcher M; Truneh A; Young PR J Biol Chem; 1998 Oct; 273(42):27548-56. PubMed ID: 9765287 [TBL] [Abstract][Full Text] [Related]
116. Cosignaling molecules around LIGHT-HVEM-BTLA: from immune activation to therapeutic targeting. Pasero C; Truneh A; Olive D Curr Mol Med; 2009 Sep; 9(7):911-27. PubMed ID: 19860669 [TBL] [Abstract][Full Text] [Related]
117. Tumor necrosis factor family members and inflammatory bowel disease. Wang J; Fu YX Immunol Rev; 2005 Apr; 204():144-55. PubMed ID: 15790356 [TBL] [Abstract][Full Text] [Related]
118. Preparation and characterization of a monoclonal antibody against the protein LIGHT. Fan K; Zhou Q; Wang H; Guo Y Hybridoma (Larchmt); 2005 Dec; 24(6):309-13. PubMed ID: 16332198 [TBL] [Abstract][Full Text] [Related]
119. Developmental regulation of sensory neurite growth by the tumor necrosis factor superfamily member LIGHT. Gavaldà N; Gutierrez H; Davies AM J Neurosci; 2009 Feb; 29(6):1599-607. PubMed ID: 19211867 [TBL] [Abstract][Full Text] [Related]